Successful Applications of Gene Therapy
Despite the number of trials, progress into actual clinical products has been slow. However, increasingly more and more clinical trials are reaching phase III and have a good chance of becoming licensed products for a range of diseases.
In humans the most successful set of trials to date have been for the severe immune deficiency disease ADA-SCID. Much of this work is being conducted by the Centre for Immunodeficiency in London.
Although not relevant to human disease, two gene therapy products have been licensed for use as veterinary medicinces. Novartis Animal Health have developed a DNA Vaccine against Infectious Salmon Anaemia and VGX Animal Health developed LifeTide, a growth hormone releasing hormone therapy aimed at improving health in farmed pigs.
Information for Patients on Our Clinical Trial
Consortium Members' Internal Website
Medical Futures Innovation Award 2011